Volume 4 - Issue 11 - November 2004
Column
Feature Interview
05/01/2008
It is exciting what it is going on now with cryo, but I think the most exciting thing is the potential particularly taking it to the left atrium in the pulmonary veins and eliminating pulmonary vein stenosis.
It is exciting what it is going on now with cryo, but I think the most exciting thing is the potential particularly taking it to the left atrium in the pulmonary veins and eliminating pulmonary vein stenosis.
It is exciting what it is going...
05/01/2008
EP Lab Digest
Feature Interview
05/01/2008
There is certainly tremendous enthusiasm for nonpharmacologic therapies, particular pulmonary vein isolation (focal AF ablation). Techniques have certainly improved, and success rates are improving.
There is certainly tremendous enthusiasm for nonpharmacologic therapies, particular pulmonary vein isolation (focal AF ablation). Techniques have certainly improved, and success rates are improving.
There is certainly tremendous...
05/01/2008
EP Lab Digest
Spotlight Interview
05/01/2008
Lisha Esbenshade-Smith, AS, RCIS, NASPExAM AP/EP/Pacing, EP Staff Educator; John Minnich, RCIS, NASPExAM AP/EP/Pacing, EP Educational Coordinator; and Tara E. Ziegler, BS, RCIS, NASPExAM AP/EP/Pacing, Supervisor, EP and Pacing Services
Lisha Esbenshade-Smith, AS, RCIS, NAS...
Our facility consists of one biplane room, two single-plane rooms, an ICD check room, and a Tilt Table Testing (TTT) room. We also share a pre- and post-procedure care unit staffed by RNs educated in both cath lab and EP procedures.
Our facility consists of one biplane room, two single-plane rooms, an ICD check room, and a Tilt Table Testing (TTT) room. We also share a pre- and post-procedure care unit staffed by RNs educated in both cath lab and EP procedures.
Our facility consists of one...
05/01/2008
EP Lab Digest
Feature Interview
05/01/2008
Bryan Burke and Scott Seagrave. Interview by Jodie Elrod.
Bryan Burke and Scott Seagrave. Inter...
Our group has a dedicated clinical trial department. We are involved in about 10 trials, about five of which have to do with EP.
Our group has a dedicated clinical trial department. We are involved in about 10 trials, about five of which have to do with EP.
Our group has a dedicated...
05/01/2008
EP Lab Digest
Feature
Feature Story
05/01/2008
Wendy Klopp, RN and Maryanne Taylor, RN
Wendy Klopp, RN and Maryanne Taylor, ...
In learning how to use the EnSite System, we have increased our knowledge of electrophysiology. We are learning much more about anatomy, pathophysiology and how the cardiac anatomy correlates with the fluoroscopic images.
In learning how to use the EnSite System, we have increased our knowledge of electrophysiology. We are learning much more about anatomy, pathophysiology and how the cardiac anatomy correlates with the fluoroscopic images.
In learning how to use the...
05/01/2008
EP Lab Digest
Review
05/01/2008
Douglas Beinborn MA, BSN, *Barbro Kjellstrom MS, *Amy Roettger RN, *Tom Bennett PhD, *Michelle Anderson BS, Michael McGoon MD
Douglas Beinborn MA, BSN, *Barbro Kje...
Use of the Chronicle Implantable Hemodynamic Monitor system has the potential to allow more precise titration of drugs by providing data continuously during rest and exercise, and when drugs and doses are modified.
Use of the Chronicle Implantable Hemodynamic Monitor system has the potential to allow more precise titration of drugs by providing data continuously during rest and exercise, and when drugs and doses are modified.
Use of the Chronicle Implantable...
05/01/2008
EP Lab Digest
Case Study
05/01/2008
Todd J. Cohen, MD and Lawrence Alpert, MD
Todd J. Cohen, MD and Lawrence Alpert...
One should consider the newer devices for cardiac resynchronization therapy. The InSync Maximo is certainly a welcome addition.
One should consider the newer devices for cardiac resynchronization therapy. The InSync Maximo is certainly a welcome addition.
One should consider the newer...
05/01/2008
EP Lab Digest
Perspectives
05/01/2008
This is a slide that, by now, everyone in an EP lab is familiar with: it is the MADIT II slide. This study dramatically changed the landscape of how we do risk stratification.
This is a slide that, by now, everyone in an EP lab is familiar with: it is the MADIT II slide. This study dramatically changed the landscape of how we do risk stratification.
This is a slide that, by now,...
05/01/2008
EP Lab Digest
Perspectives
05/01/2008
At this point, it appears that for patients who receive ICD therapy (without resynchronization therapy), minimizing unnecessary ventricular pacing is going to be the way to go in an ICD. This is the future of ICD therapy. This trial presently...
At this point, it appears that for patients who receive ICD therapy (without resynchronization therapy), minimizing unnecessary ventricular pacing is going to be the way to go in an ICD. This is the future of ICD therapy. This trial presently...
At this point, it appears that...
05/01/2008
EP Lab Digest
Department
EP 101
05/01/2008
This month, we feature 2 new questions for discussion.
This month, we feature 2 new questions for discussion.
This month, we feature 2 new...
05/01/2008
EP Lab Digest
